tickrz reports
tickrz rank
D
C R Bard Inc (BCR)
Healthcare | Health Services
318.66  -0.30%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankD / 382Warren Buffett RankC / 289
Pure Value RankD / 454Dividend RankB / 112
Moat RankB / 232Financial Strength RankA / 88
Growth RankB / 199Momentum RankA / 44
BCR vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
BCRSECTORS&P 500
P/E RATIO40.7132.119.28
EV/EBITDA RATIO25.081711.77
P/S RATIO6.13.62.03
P/B RATIO12.65.53.09
QUALITY
RETURN ON EQUITY32.96%15.64%13.82%
RETURN ON CAPITAL35.84%50.61%10.04%
NET MARGIN14.24%8.18%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.33%
PAYOUT RATIO13.44%
3 YR DIVIDEND GROWTH6.84%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY89%
INTEREST COVERAGE18.07x
CURRENT RATIO1.58
GROWTH
5 YR EPS GROWTH13.76%
5 YR SPS GROWTH5.1%
5 YR BPS GROWTH1.87%
About tickrz
Key Concepts
Great Investors
C R Bard Inc's stock has climbed 43% over the last year, earning it a strong Momentum Rank
tickrz rank D / 382
C R Bard Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking D / 454Warren Buffett ranking C / 289
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. C R Bard Inc's valuation score is comprised of a P/E ratio of 40.7x, a P/B ratio of 12.6x, a P/S ratio of 6.1x, and an EV/EBITDA ratio of 25.1x. C R Bard Inc ranks 454 out of the S&P 500 constituents on valuation--a relatively weak score.C R Bard Inc ranks 289 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, C R Bard Inc is probably not for you.

quality
moat B / 232financial strength A / 88
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.C R Bard Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 18.07x, a debt/equity ratio of 89% and a Moat Rank of 232 translate to a strong Financial Strength score.


momentum A / 44
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 43.46% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 44. C R Bard Inc's strong 12 month stock performance will appeal to momentum investors.

yield B / 112
value + yield
Shares currently yield 0.33%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, C R Bard Inc ranks 112 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth B / 199
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 13.8% 5 year annualized EPS growth, 5.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 1.9% combine to produce this average score.

C R Bard Inc (BCR)
Healthcare | Health Services
318.66  -0.30%


tickrz rank
D
VALUATION RATIOS
P/E Ratio40.71x
P/B Ratio12.6x
P/S Ratio6.1x
EV/EBITDA Ratio25.08x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.33%
PAYOUT RATIO13.44%
3 YR DIVIDEND GROWTH6.84%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY89%
INTEREST COVERAGE18.07x
CURRENT RATIO1.58
MOAT
ROE32.96%
ROIC35.84%
Net Margin14.24%
GROWTH
5 YR EPS GROWTH13.76%
5 YR SPS GROWTH5.1%
5 YR BPS GROWTH1.87%

TICKRZ RANK
C R Bard Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. C R Bard Inc's valuation score is comprised of a P/E ratio of 40.7x, a P/B ratio of 12.6x, a P/S ratio of 6.1x, and an EV/EBITDA ratio of 25.1x. C R Bard Inc ranks 454 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
C R Bard Inc ranks 289 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, C R Bard Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
C R Bard Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 18.07x, a debt/equity ratio of 89% and a Moat Rank of 232 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 43.46% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 44. C R Bard Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.33%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, C R Bard Inc ranks 112 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 13.8% 5 year annualized EPS growth, 5.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 1.9% combine to produce this average score.